[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1951

The Modern Treatment of Asthma: With Special Reference to Gold Therapy.

Author Affiliations
 

By Laszlo Banszky, M.D., (Berlin), L.M.S.S.A. (Lond.). Price, $2.50. Pp. 135, with no illustrations. Williams & Wilkins Company, Mount Royal and Guilford Aves., Baltimore 2, 1950.

AMA Arch Intern Med. 1951;87(3):472-473. doi:10.1001/archinte.1951.03810030145018

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

The author of this book considers it established that tuberculosis is the commonest cause of bronchial asthma, an idea which is not accepted by the majority of internists today. He considers that the state of sensitivity established in this fashion may be reversed by the use of gold salts in the treatment of bronchial asthma. In his hands the results have been dramatic; 55 per cent of 203 patients of all ages suffering from asthma have been completely relieved two years or more after at least one course of nine weekly injections of gold sodium thiomaleate (myochrysine®). It is entirely possible that gold is capable of relieving an occasional asthmatic person but certainly not through its antiphthisic properties. Whatever value it may have is probably mediated through the pituitary-adrenal cortex axis. In spite of the value of dimercaprol (BAL) in the control of gold toxicity, gold therapy is still a

First Page Preview View Large
First page PDF preview
First page PDF preview
×